{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:33:12Z","timestamp":1792114392005,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012276","name":"Tillotts Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.cgh.2021.07.006","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T11:20:49Z","timestamp":1625311249000},"page":"2481-2488.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["AGA Clinical Practice Update on Management of Chronic Gastrointestinal Pain in Disorders of Gut\u2013Brain Interaction: Expert Review"],"prefix":"10.1016","volume":"19","author":[{"given":"Laurie","family":"Keefer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7107-3683","authenticated-orcid":false,"given":"Cynthia W.","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2021.07.006_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study","volume":"160","author":"Sperber","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.006_bib2","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1185\/03007990802184545","article-title":"Efficacy and safety of pantoprazole 20 mg once daily treatment in patients with ulcer-like functional dyspepsia","volume":"24","author":"van Rensburg","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cgh.2021.07.006_bib3","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1136\/gut.2011.241307","article-title":"Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease","volume":"60","author":"Kahrilas","year":"2011","journal-title":"Gut"},{"issue":"Suppl 2","key":"10.1016\/j.cgh.2021.07.006_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41395-018-0084-x","article-title":"American College of Gastroenterology monograph on management of irritable bowel syndrome","volume":"113","author":"Ford","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.006_bib5","doi-asserted-by":"crossref","first-page":"E102","DOI":"10.1097\/SGA.0000000000000530","article-title":"Health-related quality of life in irritable bowel syndrome: a systematic review and meta-analysis","volume":"43","author":"Cassar","year":"2020","journal-title":"Gastroenterol Nurs"},{"key":"10.1016\/j.cgh.2021.07.006_bib6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cgh.2011.07.023","article-title":"Understanding the multidimensional nature of illness severity as measured by patient-reported outcome measures in irritable bowel syndrome","volume":"9","author":"Chang","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.006_bib7","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.cgh.2020.08.043","article-title":"The role of resilience in irritable bowel syndrome, other chronic gastrointestinal conditions, and the general population","volume":"19","author":"Parker","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.006_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2982.2010.01493.x","article-title":"Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS","volume":"22","author":"Jerndal","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2021.07.006_bib9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ajg.2013.56","article-title":"2012 David Sun lecture: helping your patient by helping yourself--how to improve the patient-physician relationship by optimizing communication skills","volume":"108","author":"Drossman","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.006_bib10","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/MCG.0b013e31825a2ff2","article-title":"The role of effective clinician-patient communication in the management of irritable bowel syndrome and chronic constipation","volume":"46","author":"Di Palma","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.006_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2011.08.009","article-title":"Development and validation of the irritable bowel syndrome satisfaction with\u00a0care scale","volume":"9","author":"Dorn","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.006_bib12","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1093\/pm\/pnz373","article-title":"Group differences between countries and between languages in pain-related beliefs, coping, and catastrophizing in chronic pain: a systematic review","volume":"21","author":"Sharma","year":"2020","journal-title":"Pain Med"},{"key":"10.1016\/j.cgh.2021.07.006_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/j.pain.0000000000000412","article-title":"Are multidisciplinary interventions multicultural? A topical review of the pain literature as it relates to culturally diverse patient groups","volume":"157","author":"Brady","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.cgh.2021.07.006_bib14","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/ajg.2012.69","article-title":"Effect of dyspepsia on survival: a longitudinal 10-year follow-up study","volume":"107","author":"Ford","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.006_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1533-2500.2005.05203.x","article-title":"Evolution of the neuromatrix theory of pain. The Prithvi Raj lecture: presented at the third World Congress of World Institute of Pain, Barcelona 2004","volume":"5","author":"Melzack","year":"2005","journal-title":"Pain Pract"},{"key":"10.1016\/j.cgh.2021.07.006_bib16","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neubiorev.2008.07.008","article-title":"The sensory-discriminative and affective-motivational aspects of pain","volume":"34","author":"Auvray","year":"2010","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.cgh.2021.07.006_bib17","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/j.pain.0000000000000574","article-title":"The fear-avoidance model of pain","volume":"157","author":"Vlaeyen","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.cgh.2021.07.006_bib18","first-page":"24","article-title":"Baseline psychological inflexibility moderates the outcome pain interference in a randomized controlled trial on internet-based acceptance and commitment therapy for chronic pain","volume":"8","author":"Probst","year":"2018","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cgh.2021.07.006_bib19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/AJP.0000000000000870","article-title":"Anxiety, depression, and opioid misuse among adults with chronic pain: the role of anxiety sensitivity","volume":"36","author":"Rogers","year":"2020","journal-title":"Clin J Pain"},{"key":"10.1016\/j.cgh.2021.07.006_bib20","first-page":"507","article-title":"Effects of context and individual predispositions on hypervigilance to pain-cues: an ERP study","volume":"8","author":"Dittmar","year":"2015","journal-title":"J\u00a0Pain Res"},{"key":"10.1016\/j.cgh.2021.07.006_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.12982","article-title":"The impact of irritable bowel syndrome on daily functioning: characterizing and understanding daily consequences of IBS","author":"Ballou","year":"2017","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2021.07.006_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/fampra\/cmz046","article-title":"Utility of catastrophizing, body symptom diagram score and history of opioid use to predict future health care utilization after a primary care visit for musculoskeletal pain","volume":"37","author":"Rhon","year":"2020","journal-title":"Fam Pract"},{"key":"10.1016\/j.cgh.2021.07.006_bib23","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cgh.2011.08.008","article-title":"Increasing frequency of opioid prescriptions for chronic abdominal pain in US outpatient clinics","volume":"9","author":"Dorn","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.006_bib24","series-title":"Opioid treatments for chronic pain","author":"Chou","year":"2020"},{"key":"10.1016\/j.cgh.2021.07.006_bib25","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1097\/MIB.0000000000000194","article-title":"Narcotic use and misuse in Crohn's disease","volume":"20","author":"Crocker","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2021.07.006_bib26","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/apt.14503","article-title":"Opioid medication use in patients with gastrointestinal diagnoses vs unexplained gastrointestinal symptoms in the US Veterans Health Administration","volume":"47","author":"Sayuk","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.006_bib27","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2982.2009.01458.x","article-title":"Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain","volume":"22","author":"Tuteja","year":"2010","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2021.07.006_bib28","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ajg.2012.142","article-title":"Diagnosis, characterization, and 3-month outcome after detoxification of 39 patients with narcotic bowel syndrome","volume":"107","author":"Drossman","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.006_bib29","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.36076\/ppj.2017.s92","article-title":"Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines","volume":"20","author":"Manchikanti","year":"2017","journal-title":"Pain Physician"},{"key":"10.1016\/j.cgh.2021.07.006_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.cgh.2021.07.006_bib31","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2018.01.045","article-title":"Best practice update: incorporating psychogastroenterology into management of digestive disorders","volume":"154","author":"Keefer","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.006_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/PRBM.S120817","article-title":"Cognitive-behavioral therapy for patients with irritable bowel syndrome: current insights","volume":"10","author":"Kinsinger","year":"2017","journal-title":"Psychol Res Behav Manag"},{"key":"10.1016\/j.cgh.2021.07.006_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41395-018-0222-5","article-title":"Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis","volume":"114","author":"Ford","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.006_bib34","doi-asserted-by":"crossref","first-page":"e13573","DOI":"10.1111\/nmo.13573","article-title":"Gut-focused hypnotherapy for functional gastrointestinal disorders: evidence-base, practical aspects, and the Manchester Protocol","volume":"31","author":"Vasant","year":"2019","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2021.07.006_bib35","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ajg.2013.19","article-title":"Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial","volume":"108","author":"Moser","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.006_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/00207144.2019.1553766","article-title":"Skype hypnotherapy for irritable bowel syndrome: effectiveness and comparison with face-to-face treatment","volume":"67","author":"Hasan","year":"2019","journal-title":"Int J Clin Exp Hypn"},{"key":"10.1016\/j.cgh.2021.07.006_bib37","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/ajg.2011.184","article-title":"Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial","volume":"106","author":"Gaylord","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.006_bib38","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/AJP.0000000000000425","article-title":"Acceptance and commitment therapy (ACT) for chronic pain: a systematic review and meta-analyses","volume":"33","author":"Hughes","year":"2017","journal-title":"Clin J Pain"},{"key":"10.1016\/j.cgh.2021.07.006_bib39","doi-asserted-by":"crossref","first-page":"648","DOI":"10.17235\/reed.2017.4660\/2016","article-title":"New psychological therapies for irritable bowel syndrome: mindfulness, acceptance and commitment therapy (ACT)","volume":"109","author":"Sebastian Sanchez","year":"2017","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.cgh.2021.07.006_bib40","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/BF02212678","article-title":"Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity","volume":"40","author":"Trimble","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2021.07.006_bib41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0304-3959(01)00285-8","article-title":"Hypersensitivity to visceral and cutaneous pain in the irritable bowel syndrome","volume":"93","author":"Verne","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.cgh.2021.07.006_bib42","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.gastro.2007.11.011","article-title":"Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study","volume":"134","author":"Ringel","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.006_bib43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/nmo.12489","article-title":"Neural circuitry of abdominal pain-related fear learning and reinstatement in irritable bowel syndrome","volume":"27","author":"Icenhour","year":"2015","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.cgh.2021.07.006_bib44","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/gutjnl-2018-318160","article-title":"Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis","volume":"69","author":"Black","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2021.07.006_bib45","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1053\/j.gastro.2018.08.021","article-title":"Efficacy of secretagogues in patients with irritable bowel syndrome with constipation: systematic review and network meta-analysis","volume":"155","author":"Black","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.006_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2468-1253(19)30324-3","article-title":"Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis","volume":"5","author":"Black","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.006_bib47","first-page":"1906","article-title":"Tegaserod treatment for dysmotility-like functional dyspepsia: results of two randomized, controlled trials","volume":"103","author":"Vakil","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.006_bib48","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/apt.13945","article-title":"Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia","volume":"45","author":"Tan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.006_bib49","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2017.11.279","article-title":"Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a Rome Foundation working team report","volume":"154","author":"Drossman","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.006_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG clinical guideline: management of irritable bowel syndrome","volume":"116","author":"Lacy","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.006_bib51","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1053\/j.gastro.2014.09.001","article-title":"American Gastroenterological Association Institute guideline on the pharmacological management of irritable bowel syndrome","volume":"147","author":"Weinberg","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.07.006_bib52","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ajg.2015.413","article-title":"Imipramine for treatment of esophageal hypersensitivity and functional heartburn: a randomized placebo-controlled trial","volume":"111","author":"Limsrivilai","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.006_bib53","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/ajg.2011.179","article-title":"Selective serotonin reuptake inhibitors for the treatment of hypersensitive esophagus: a randomized, double-blind, placebo-controlled study","volume":"107","author":"Viazis","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.07.006_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/apt.16072","article-title":"Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia","volume":"53","author":"Ford","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2021.07.006_bib55","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.cgh.2008.02.051","article-title":"Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial","volume":"6","author":"van Kerkhoven","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.006_bib56","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/hup.1038","article-title":"Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot study","volume":"24","author":"Brennan","year":"2009","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.cgh.2021.07.006_bib57","first-page":"CD007115","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","volume":"1","author":"Lunn","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2021.07.006_bib58","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1468-1331.2009.02648.x","article-title":"A\u00a0double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain","volume":"16","author":"Skljarevski","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.cgh.2021.07.006_bib59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cgh.2015.09.043","article-title":"Efficacy of mirtazapine in patients with functional dyspepsia and weight loss","volume":"14","author":"Tack","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.07.006_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13030-021-00205-2","article-title":"A\u00a0randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the treatment of diarrhea predominant irritable bowel syndrome","volume":"15","author":"Khalilian","year":"2021","journal-title":"Biopsychosoc Med"},{"key":"10.1016\/j.cgh.2021.07.006_bib61","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1007\/s10620-006-9289-8","article-title":"Low-dose naltreoxone for the treatment of irritable bowel syndrome: a pilot study","volume":"51","author":"Kariv","year":"2006","journal-title":"Dig Dis Sci"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521007175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521007175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:37:46Z","timestamp":1761543466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356521007175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1542356521007175"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2021.07.006","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AGA Clinical Practice Update on Management of Chronic Gastrointestinal Pain in Disorders of Gut\u2013Brain Interaction: Expert Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2021.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the AGA Institute","name":"copyright","label":"Copyright"}]}}